Sources familiar with the situation have revealed on Sunday that Pfizer Inc. is in advanced talks to acquire cancer drug company Medivation Inc. for close to $14 billion. In an effort to boost it oncology porfolio, Pfizer has agreed to pay a little more than $80 per share for Medivation. Medivation only put itself up … Continue reading “Pfizer (PFE) In Talks To Acquire This Major Company”
